Literature DB >> 19289788

Type 1 leprosy reaction manifesting after discontinuation of adalimumab therapy.

Ivan D Camacho, Isabel Valencia, Maria P Rivas, Anne E Burdick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19289788     DOI： 10.1001/archdermatol.2009.10

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  2 in total

Review 1.  Development of lepromatous leprosy following etanercept treatment for arthritis.

Authors:  Charalampos Lydakis; Despina Ioannidou; Irini Koumpa; Elpida Giannikaki; Evaggelos Thalassinos; Eleni Krasoudaki; Spiros Miyakis
Journal:  Clin Rheumatol       Date:  2011-12-15       Impact factor: 2.980

2.  Biologics in Leprosy: A Systematic Review and Case Report.

Authors:  Anna L Cogen; Eglantine Lebas; Barbara De Barros; James P Harnisch; William R Faber; Diana N Lockwood; Stephen L Walker
Journal:  Am J Trop Med Hyg       Date:  2020-05       Impact factor: 2.345
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.